
Investing.com – U.S. stocks were mixed after the close on Monday, as gains in the Technology, Basic Materials and Utilities sectors led shares higher while losses in the Healthcare, Telecoms and Oil&Gas sectors led shares lower.
At the close in NYSE, the Dow Jones Industrial Average fell 0.34%, while the S&P 500 index declined 0.08%, and the NASDAQ Composite index climbed 0.63%.
The best performers of the session on the Dow Jones Industrial Average were Salesforce Inc (NYSE:CRM), which rose 4.68% or 6.58 points to trade at 147.09 at the close. Meanwhile, Intel Corporation (NASDAQ:INTC) added 2.02% or 0.58 points to end at 29.31 and Goldman Sachs Group Inc (NYSE:GS) was up 1.41% or 4.92 points to 353.00 in late trade.
The worst performers of the session were Merck&Company Inc (NYSE:MRK), which fell 3.88% or 4.46 points to trade at 110.38 at the close. Johnson&Johnson (NYSE:JNJ) declined 2.60% or 4.68 points to end at 175.57 and The Travelers Companies Inc (NYSE:TRV) was down 2.44% or 4.73 points to 189.14.
The top performers on the S&P 500 were Tesla Inc (NASDAQ:TSLA) which rose 5.93% to 119.77, Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) which was up 5.90% to settle at 13.81 and NVIDIA Corporation (NASDAQ:NVDA) which gained 5.18% to close at 156.28.
The worst performers were Baxter International Inc (NYSE:BAX) which was down 7.74% to 44.70 in late trade, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) which lost 7.69% to settle at 680.49 and Northrop Grumman Corporation (NYSE:NOC) which was down 4.99% to 495.41 at the close.
The top performers on the NASDAQ Composite were CinCor Pharma Inc (NASDAQ:CINC) which rose 143.97% to 28.74, Amryt Pharma Holdings Ltd (NASDAQ:AMYT) which was up 106.99% to settle at 14.51 and Albireo Pharma Inc (NASDAQ:ALBO) which gained 92.16% to close at 43.85.
The worst performers were Calithera Biosciences Inc (NASDAQ:CALA) which was down 81.77% to 0.66 in late trade, Peak Bio Inc (NASDAQ:PKBO) which lost 27.27% to settle at 2.56 and Cerus Corporation (NASDAQ:CERS) which was down 28.04% to 2.72 at the close.
Rising stocks outnumbered declining ones on the New York Stock Exchange by 1872 to 1197 and 98 ended unchanged; on the Nasdaq Stock Exchange, 2196 rose and 1578 declined, while 141 ended unchanged.
Shares in Baxter International Inc (NYSE:BAX) fell to 5-year lows; falling 7.74% or 3.75 to 44.70. Shares in Calithera Biosciences Inc (NASDAQ:CALA) fell to all time lows; losing 81.77% or 2.96 to 0.66. Shares in Amryt Pharma Holdings Ltd (NASDAQ:AMYT) rose to 52-week highs; rising 106.99% or 7.50 to 14.51. Shares in Peak Bio Inc (NASDAQ:PKBO) fell to all time lows; down 27.27% or 0.96 to 2.56. Shares in Albireo Pharma Inc (NASDAQ:ALBO) rose to 5-year highs; gaining 92.16% or 21.03 to 43.85. Shares in Cerus Corporation (NASDAQ:CERS) fell to 5-year lows; down 28.04% or 1.06 to 2.72.
The CBOE Volatility Index, which measures the implied volatility of S&P 500 options, was up 3.98% to 21.97.
Gold Futures for February delivery was up 0.33% or 6.10 to $1,875.80 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in February rose 1.44% or 1.06 to hit $74.83 a barrel, while the March Brent oil contract rose 1.46% or 1.15 to trade at $79.72 a barrel.
EUR/USD was up 0.83% to 1.07, while USD/JPY fell 0.19% to 131.82.
The US Dollar Index Futures was down 0.68% at 102.94.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.